|CANCER & TREATMENTS FOR CANCER CENTER PATIENTS PREVENTION & RISK ASSESSMENT CLINICAL TRIALS & RESEARCH LIVING WITH CANCER|
U-M researcher wins award for Distinguished Research in Biomedical Sciences
Colleagues say his work has transformed the genetics of hemostasis and thrombosis-added 10/29/10
Ann Arbor - The Association of American Medical Colleges has recognized University of Michigan Medical School researcher David Ginsburg, M.D., with the Distinguished Research in the Biomedical Sciences Award.
Ginsburg is one of 10 scientists in the country receiving national recognition for their outstanding contributions to academic medicine and the global community. The awards will be presented on Saturday, Nov. 6, during the association's annual meeting in Washington, D.C. For more information, visit www.aamc.org/initiatives/awards/2010/.
A graduate of the Duke University School of Medicine, today, in addition to being certified in four different specialties--hematology, oncology, internal medicine, and clinical genetics -- Ginsburg is an internationally recognized researcher who has devoted his career to finding better ways to treat inherited bleeding and clotting diseases, with a focus on the most frequent disorder of hemostasis, von Willebrand Disease (VWD).
Ginsburg is James V. Neel Distinguished University Professor and Warner-Lambert/Parke-Davis Professor in the departments of internal medicine, pediatrics and human genetics at the U-M Medical School. Ginsburg joined the faculty at the University of Michigan as an Assistant Professor in 1985. He is also a member of the U-M Comprehensive Cancer Center and the Life Sciences Institute.
In 1985, while working as a research fellow at the Dana Farber Cancer Institute, Ginsburg became the first to isolate cDNA encoding the von Willebrand factor and was among the first to clone its gene. He then went on to study combined blood factor V and VIII deficiency, a rare inherited bleeding disorder that affects families around the world and is concentrated in the Middle East. From there, Ginsburg and his team of investigators discovered the cause of thrombotic thrombocytopenic purpura (TTP), an inherited blood-clotting disorder that, left untreated, can cause fatal kidney failure or stroke.
Ginsburg has served on and led numerous research and advisory committees in the United States and abroad, including many programs at the National Institutes of Health. He was a member of the Recombinant DNA Advisory Committee, has chaired the Board of Scientific Counselors for both the National Human Genomic Research Institute and the National Center for Biotechnology Information, and currently serves on the Advisory Committee to the Director of the NIH, among many other positions.
Ginsburg is a former president of the American Society for Clinical Investigation and, currently serves on the Councils for the National Academy of Sciences and for the Institute of Medicine.
Additional links:University of Michigan Medical School
Written by Margarita B. Wagerson, contact by E-mail: email@example.com or Phone: 734-764-2220